ConvaTec Group (LON:CTEC) Earns “Buy” Rating from Berenberg Bank

Berenberg Bank restated their buy rating on shares of ConvaTec Group (LON:CTEC) in a research note issued to investors on Wednesday,London Stock Exchange reports. They currently have a GBX 310 ($4.00) price objective on the stock.

ConvaTec Group Price Performance

Shares of CTEC stock traded down GBX 3 ($0.04) during mid-day trading on Wednesday, hitting GBX 266.40 ($3.43). 30,871,107 shares of the stock were exchanged, compared to its average volume of 13,549,809. ConvaTec Group has a 52-week low of GBX 211.80 ($2.73) and a 52-week high of GBX 295.20 ($3.81). The company has a quick ratio of 0.96, a current ratio of 2.26 and a debt-to-equity ratio of 85.32. The firm has a fifty day moving average of GBX 239.15 and a 200 day moving average of GBX 232.91. The company has a market cap of £6.77 billion, a PE ratio of 44.86, a price-to-earnings-growth ratio of 0.93 and a beta of 0.64.

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.